Alveolar type II pneumocyte (null)

Alveolar type II pneumocyte Overview

Alveolar type II pneumocytes are specialized cuboidal epithelial cells located in the alveoli of the lung that are primarily responsible for the synthesis, storage, and secretion of pulmonary surfactant, a lipoprotein complex crucial for reducing surface tension and preventing alveolar collapse at end-expiration. These cells also contribute to alveolar repair by proliferating and differentiating into type I pneumocytes after injury, and play important roles in innate immune defense by modulating local inflammation and secreting collectins such as SP-A and SP-D for pathogen clearance. They account for a small percentage of the alveolar surface but represent the majority of alveolar epithelial cell numbers. Critical Note: The entry "Surfactant-producing type II pneumocyte" refers to a cell type that produces surfactant, not a molecular (drug or ligand) target such as a receptor, enzyme, ion channel, or transporter; thus, it does not correspond to a canonical molecular drug target class. For a pharmaceutically actionable target, it is more appropriate to specify molecular components *of* the cell, such as “Pulmonary surfactant protein B (SP-B)” or “Surfactant protein C (SP-C),” rather than the entire cell type.

Mechanism of Action

Surfactant therapy replaces endogenous surfactant to restore surface tension regulation and improve alveolar stability

Biological Functions

Safety Considerations

Interacting Drugs

Associated Biomarkers